Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

tillotts pharma ag - menthae piperitae aetheroleum - capsules - menthae piperitae aetheroleum 187 mg, color.: e 132, excipiens pro de la capsule. - reizkolon, des crampes intestinales - phytoarzneimittel

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

tillotts pharma ag - budesonidum - lavement - i) dispergierbare tablette: budesonidum 2.3 mg, lactosum, riboflavini natrii phosphas, crospovidonum, silica colloidalis anhydrica, magnesii stearas pro compresso. ii) vehikel: e 218 80 mg, propylis parahydroxybenzoas 20 mg, natrii chloridum, aqua purificata ad solutionem pro 100 ml. suspensio reconstituta: budesonidum 2 mg, lactosum, riboflavini natrii phosphas, crospovidonum, silica colloidalis anhydrica, magnesii stearas, e 218 80 mg, propylis parahydroxybenzoas 20 mg, natrii chloridum, aqua purificata ad suspensionem pro 100 ml. - la colite ulcéreuse - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

tillotts pharma ag - mesalazinum - comprimé gastro-résistant - mesalazinum 400 mg, lactosum monohydricum 76.4 mg, carboxymethylamylum natricum a corresp. natrium 0.768 mg, magnesii stearas, talcum, povidonum k 25, Überzug: acidi methacrylici et methylis methacrylatis polymerisatum 1:2, talcum, triethylis citras, macrogolum 6000, e 172, pro compresso obducto. - la colite ulcéreuse - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

tillotts pharma ag - mesalazinum - magensaftesistente comprimé - mesalazinum 800 mg, lactosum monohydricum 153 mg, carboxymethylamylum natricum a corresp. natrium 1.537 mg, magnesii stearas, talcum, povidonum k 25, Überzug: acidi methacrylici et methylis methacrylatis polymerisatum 1:2, talcum, triethylis citras, macrogolum 6000, e 172, pro compresso obducto. - la colite ulcéreuse - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

tillotts pharma ag - mesalazinum - suppositoires - mesalazinum 0.5 g, adeps solidus, pro suppositorio. - proktitis ulcérative - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

tillotts pharma ag - mesalazinum - comprimé gastro-résistant - mesalazinum 1600 mg, cellulosum microcristallinum, carboxymethylamylum natricum a corresp. natrium 2.268 mg, hypromellosum, silica colloidalis, magnesii stearas, Überzug: hypromellosum, macrogolum 6000, acidi methacrylici et methylis methacrylatis polymerisatum 1:2, triethylis citras, glyceroli monostearas 40-55, polysorbatum 80, kalii dihydrogenophosphas, maydis amylum, e 172, pro compresso obducto. - la colite ulcéreuse - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

tillotts pharma ag - mesalazinum - suppositoires - mesalazinum 1 g, adeps solidus, pro suppositorio. - proktitis ulcérative - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

tillotts pharma ag - budesonidum - hartkapsel mit veränderter wirkstofffreisetzung - budesonidum 3 mg, tributylis acetylcitras, simeticonum, ethylcellulosum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, polysorbatum 80, sacchari sphaerae 320 mg, talcum, triethylis citras, kapselhülle: gelatina, paraffinum liquidum, silica colloidalis anhydrica, natrii laurilsulfas corresp. natrium 11.96 µg, e 171, e 172 (rubrum), e 172 (nigrum), e 172 (flavum), drucktinte: ammonii hydroxidum, e 172 (nigrum), kalii hydroxidum, lacca, pro capsula. - morbus crohn, mikroskopische kolitis - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

tillotts pharma ag - fidaxomicinum - comprimés pelliculés - fidaxomicinum 200 mg, antiox.: e 321, excipiens pro compresso de la brume. - clostridium-difficile-assozierte diarrhoe macd - synthetika

Canada - français - Health Canada

tillotts pharma ag - mésalazine - comprimé (à libération retardée) - 800mg - mésalazine 800mg - anti-inflammatory agents